InvestorsHub Logo
icon url

brickbybrick

12/23/12 2:48 PM

#25461 RE: Solantey #25460

3 million is nothing when you're talking about billion dollar potential and a blockbuster drug.
icon url

Kgs68

12/23/12 2:53 PM

#25462 RE: Solantey #25460

Hire this guy Gerald!

Again, it would include the guy who cofounded AMGM, insiders from Bayer, NFL, etc, insider at the AMA, etc, all with serious and proven track record...and wait for it...Solantey.

You're really just embarrassing yourself...
icon url

Masala

12/23/12 3:07 PM

#25465 RE: Solantey #25460

Glad you sold,you wouldn't see the $500,000,000 hole it might take to get the drug to market it is called 'investing' is not disgusting which is so interesting.
icon url

familyof5

12/23/12 3:33 PM

#25467 RE: Solantey #25460

Solantey Wednesday, December 19, 2012 8:35:16 AM
Re: None



"AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012."
Solantey





http://investorshub.advfn.com/boards/read_msg.aspx?message_id=82611213


"Big pharma" development partnership(s) or buyout in 2013.

$1.00 or more.

Major drug companies have billions of dollars to spend on acquisitions or partnerships.

AMBS is the most undervalued bio-tech in the market.

.20-.25 by 12/31/2012.

The co-founder of Amgen is 100% correct when he stated that the company's MANF technology would be worth billions and be a blockbuster drug.






"I have been driven many times upon my knees by the overwhelming conviction that I had nowhere else to go."
Abraham Lincoln

"Jesus.....wise men still seek him"
icon url

SonarX2

12/23/12 4:04 PM

#25470 RE: Solantey #25460

silly..
seller sold.. outa fear..
now trying to bash their way back in.